|
1
|
Foley RN and Parfrey PS: Cardiovascular
disease and mortality in ESRD. J Nephrol. 11:239–245.
1998.PubMed/NCBI
|
|
2
|
Goodman WG, Goldin J, Kuizon BD, et al:
Coronary-artery calcification in young adults with end-stage renal
disease who are undergoing dialysis. N Engl J Med. 342:1478–1483.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Blacher J, Guerin AP, Pannier B, Marchais
SJ and London GM: Arterial calcifications, arterial stiffness, and
cardiovascular risk in end-stage renal disease. Hypertension.
38:938–942. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Scatena M, Liaw L and Giachelli CM:
Osteopontin: a multifunctional molecule regulating chronic
inflammation and vascular disease. Arterioscler Thromb Vasc Biol.
27:2302–2309. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
O’Neill WC: Mineral complexes and vascular
calcification. Kidney Int. 76:915–916. 2009. View Article : Google Scholar
|
|
6
|
Zarjou A, Jeney V, Arosio P, et al:
Ferritin prevents calcification and osteoblastic differentiation of
vascular smooth muscle cells. J Am Soc Nephrol. 20:1254–1263. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Geiger H and Wanner C: Magnesium in
disease. Clin Kidney J. 5(Suppl 1): i25–i38. 2012. View Article : Google Scholar
|
|
8
|
Spiegel DM and Farmer B: Long-term effects
of magnesium carbonate on coronary artery calcification and bone
mineral density in hemodialysis patients: a pilot study. Hemodial
Int. 13:453–459. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Massy ZA and Drüeke TB: Magnesium and
outcomes in patients with chronic kidney disease: focus on vascular
calcification, atherosclerosis and survival. Clin Kidney J. 5(Suppl
1): i52–i61. 2012. View Article : Google Scholar
|
|
10
|
Louvet L, Büchel J, et al: Magnesium
prevents phosphate-induced calcification in human aortic vascular
smooth muscle cells. Nephrol Dial Transplant. 28:869–878. 2013.
View Article : Google Scholar :
|
|
11
|
Kircelli F, Peter ME, Sevinc Ok E, et al:
Magnesium reduces calcification in bovine vascular smooth muscle
cells in a dose-dependent manner. Nephrol Dial Transplant.
27:514–521. 2012. View Article : Google Scholar :
|
|
12
|
Cai Y, Teng X, Pan CS, Duan XH, Tang CS
and Qi YF: Adrenomedullin up-regulates osteopontin and attenuates
vascular calcification via the cAMP/PKA signaling pathway. Acta
Pharmacol Sin. 31:1359–1366. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Carbone L: Pain management standards in
the eighth edition of the Guide for the Care and Use of Laboratory
Animals. J Am Assoc Lab Anim Sci. 51:322–328. 2012.PubMed/NCBI
|
|
14
|
Mizobuchi M, Towler D and Slatopolsky E:
Vascular calcification: the killer of patients with chronic kidney
disease. J Am Soc Nephrol. 20:1453–1464. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Pun PH, Smarz TR, Honeycutt EF, Shaw LK,
Al-Khatib SM and Middleton JP: Chronic kidney disease is associated
with increased risk of sudden cardiac death among patients with
coronary artery disease. Kidney Int. 76:652–658. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tzanakis I, Pras A, Kounali D, et al:
Mitral annular calcifications in haemodialysis patients: a possible
protective role of magnesium. Nephrol Dial Transplant.
12:2036–2037. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tzanakis I, Virvidakis K, Tsomi A, et al:
Intra- and extracellular magnesium levels and atheromatosis in
haemodialysis patients. Magnes Res. 17:102–108. 2004.PubMed/NCBI
|
|
18
|
Turgut F, Kanbay M, Metin MR, Uz E, Akcay
A and Covic A: Magnesium supplementation helps to improve carotid
intima media thickness in patients on hemodialysis. Int Urol
Nephrol. 40:1075–1082. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Montezano AC, Zimmerman D, Yusuf H, et al:
Vascular smooth muscle cell differentiation to an osteogenic
phenotype involves TRPM7 modulation by magnesium. Hypertension.
56:453–462. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Jono S, McKee MD, Murry CE, et al:
Phosphate regulation of vascular smooth muscle cell calcification.
Circ Res. 87:E10–E17. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sun Y, Byon CH, Yuan K, et al: Smooth
muscle cell-specific runx2 deficiency inhibits vascular
calcification. Circ Res. 111:543–552. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhong H, Liu F, Dai X, Zhou L and Fu P:
Sodium thiosulfate protects human aortic smooth muscle cells from
osteoblastic transdifferentiation via high-level phosphate.
Kaohsiung J Med Sci. 29:587–593. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Steitz SA, Speer MY, Curinga G, et al:
Smooth muscle cell phenotypic transition associated with
calcification: upregulation of Cbfa1 and downregulation of smooth
muscle lineage markers. Circ Res. 89:1147–1154. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Moe SM, Duan D, Doehle BP, O’Neill KD and
Chen NX: Uremia induces the osteoblast differentiation factor Cbfa1
in human blood vessels. Kidney Int. 63:1003–1011. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Luo G, Ducy P, McKee MD, et al:
Spontaneous calcification of arteries and cartilage in mice lacking
matrix GLA protein. Nature. 386:78–81. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Boström K, Tsao D, Shen S, Wang Y and
Demer LL: Matrix GLA protein modulates differentiation induced by
bone morphogenetic protein-2 in C3H10T1/2 cells. J Biol Chem.
276:14044–14052. 2001.PubMed/NCBI
|
|
27
|
Wada T, McKee MD, Steitz S and Giachelli
CM: Calcification of vascular smooth muscle cell cultures:
inhibition by osteopontin. Circ Res. 84:166–178. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Speer MY, McKee MD, Guldberg RE, et al:
Inactivation of the osteopontin gene enhances vascular
calcification of matrix Gla protein-deficient mice: evidence for
osteopontin as an inducible inhibitor of vascular calcification in
vivo. J Exp Med. 196:1047–1055. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
He Y, Yao G, Savoia C and Touyz RM:
Transient receptor potential melastatin 7 ion channels regulate
magnesium homeostasis in vascular smooth muscle cells: role of
angiotensin II. Circ Res. 96:207–215. 2005. View Article : Google Scholar
|
|
30
|
Paravicini TM, Chubanov V and Gudermann T:
TRPM7: a unique channel involved in magnesium homeostasis. Int J
Biochem Cell Biol. 44:1381–1384. 2012. View Article : Google Scholar : PubMed/NCBI
|
